Cases 1 - 10 of 26
Tobin v. Novartis Pharmaceuticals Corporation
as 1:2021cv10180
Defendant:
Novartis Pharmaceuticals Corporation
Plaintiff:
Margaret Tobin
Cause Of Action: 28 U.S.C. § 1441 Notice of Removal
In Re: Ranbaxy Generic Drug Application Antitrust Litigation
as 1:2019md02878
In Re:
Ranbaxy Generic Drug Application Antitrust Litigation
Plaintiff:
Meijer, Inc., Meijer Distribution, Inc., Cesar Castillo, Inc. and others
Defendant:
Ranbaxy Laboratories Limited, Sun Pharmaceutical Industries Limited, Ranbaxy, Inc. and others
Consolidated Plaintiff:
United Food and Commercial Workers Health and Welfare Fund of Northern Pennsylvania and Louisiana Health Services and Indemnity Company d/b/a Blue Cross and Blue Shield of Louisiana
Respondent:
Prinston Pharmaceutical Inc.
Interested Party:
Novartis Pharmaceuticals Corporation and Astrazeneca Pharmaceuticals L.P.
Not Classified By Court:
Winifred Weitsen
Cause Of Action: 18 U.S.C. § 1962 Racketeering (RICO) Act
Genzyme Corporation v. Dotter
as 1:2018cv11940
Plaintiff:
Genzyme Corporation
Defendant:
Thomas Dotter and Novartis Pharmaceuticals Corporation
Cause Of Action: 28 U.S.C. § 1332
Cain v. GlaxoSmithKline LLC et al
as 1:2017cv12234
Plaintiff:
Amber Cain
Defendant:
GlaxoSmithKline LLC and Novartis Pharmaceuticals Corporation
Cause Of Action: 28 U.S.C. § 1332
Kitchens v. GlaxoSmithKline LLC et al
as 1:2017cv11037
Plaintiff:
Angel Kitchens
Defendant:
GlaxoSmithKline LLC and Novartis Pharmaceuticals Corporation
Cause Of Action: 28 U.S.C. § 1332
Perry v. GlaxoSmithKline, LLC et al
as 1:2017cv10763
Plaintiff:
Deona Perry
Defendant:
GlaxoSmithKline, LLC and Novartis Pharmaceuticals Corporation
Cause Of Action: 28 U.S.C. § 1332
Bell v. GlaxoSmithKline LLC et al
as 1:2017cv10638
Plaintiff:
Trace Bell
Defendant:
GlaxoSmithKline LLC and Novartis Pharmaceuticals Corporation
Cause Of Action: 28 U.S.C. § 1332
Sperbeck-Griffin v. GlaxoSmithKline, LLC et al
as 1:2017cv10097
Plaintiff:
Brooke Sperbeck-Griffin
Defendant:
GlaxoSmithKline LLC and Novartis Pharmaceuticals Corporation
Cause Of Action: 28 U.S.C. § 1332
Printz v. GlaxoSmithKline, LLC et al
as 1:2017cv10099
Plaintiff:
Zoe Printz
Defendant:
GlaxoSmithKline LLC and Novartis Pharmaceuticals Corporation
Cause Of Action: 28 U.S.C. § 1332
Mellon v. GlaxoSmithKline, LLC et al
as 1:2017cv10098
Plaintiff:
Natoshia Mellon
Defendant:
GlaxoSmithKline LLC and Novartis Pharmaceuticals Corporation
Cause Of Action: 28 U.S.C. § 1332
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
